Career Enhancement Program
Career Enhancement Program
批准号:
10016191
负责人:
DANIEL W. LIN
金额:
$8.32万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-19 至 2023-08-31
关键词:
AreaBasic ScienceBiologyCancer EtiologyCessation of lifeClinicalClinical SciencesCollaborationsDisciplineDiseaseEducationExposure toFacultyFundingGeneral HospitalsGoalsGrantGuidelinesHealth SciencesIndividualInstitutesInstitutionMalignant neoplasm of prostateMentorsMinorityMissionMonitorOregonPacific NorthwestPatient-Focused OutcomesPopulationPopulation SciencesPreparationProceduresProcessProstateRecruitment ActivityResearchResearch ActivityResearch PersonnelResearch SupportResourcesScientistSiteSystemTalentsTimeTrainingTranslational ResearchUnderrepresented MinorityUniversitiesWashingtonWomanWorkanticancer researchcareercareer developmentexperiencefaculty mentorfaculty researchfollow-upimproved outcomeinterestmembermenmultidisciplinaryorganizational structureprogramsrecruitsuccesssymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The Career Enhancement Program (CEP) is an essential component of the PNW Prostate Cancer SPORE
that serves to sustain and enhance our mission by attracting and nurturing new and talented research faculty.
The CEP will continue to implement a strategy that has successfully developed clinical, basic, and population
scientists for productive careers in translational prostate cancer research.
The Specific Aims of the CEP are to:
1. Provide research support and collaborative expertise for junior faculty, advanced fellows, and established
investigators who wish to either develop or refocus their careers on translational PC research;
2. Provide a coordinated system for mentoring faculty and advanced fellows pursuing PC research across a
broad range of disciplines;
3. Create a framework in which investigators can gain exposure to and training in aspects of translational PC
research outside their areas of expertise; and
4. Attract and retain women, minorities, and early career junior faculty who can make key contributions to
translational PC research at the institutions comprising the PNW Prostate SPORE.
The CEP will be coordinated between the Fred Hutch and the University of Washington (UW); the Prostate
Centre at the Vancouver General Hospital (VGH); and the Oregon Health Science University (OHSU). Our
organizational structure works across sites and includes recruitment and monitoring of candidates by a career
enhancement committee, educational coordination through a conference and education committee, and access
to more than 50 multidisciplinary investigators both within and outside the SPORE whose research interests
provide relevant experience in translational prostate cancer research. The CEP educational program combines
a wide spectrum of individual research opportunities, formal educational courses, and a large number of
conferences and seminars in translational prostate cancer research. We plan to continue to recruit both qualified
faculty members and senior research fellows who wish to expand their work in translational prostate cancer
research, focusing on the inclusion of women and underrepresented minority applicants. In addition to SPORE
grant support, this program will be augmented by substantial institutional resources.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prostate cancer Active Surveillance Study (PASS) Cohort: Infrastructure Support for Cancer Research
-
批准号:10221640
-
项目类别:
-
资助金额:$63.95万
-
财政年份:2019
-
负责人:DANIEL W. LIN
-
依托单位:
Prostate cancer Active Surveillance Study (PASS) Cohort: Infrastructure Support for Cancer Research
-
批准号:10463567
-
项目类别:
-
资助金额:$127.8万
-
财政年份:2019
-
负责人:DANIEL W. LIN
-
依托单位:
Evaluation of commercially available prostate cancer assays to accelerate novel applications in active surveillance
-
批准号:10020364
-
项目类别:
-
资助金额:$32.71万
-
财政年份:2019
-
负责人:DANIEL W. LIN
-
依托单位:
Evaluation of commercially available prostate cancer assays to accelerate novel applications in active surveillance
-
批准号:10217046
-
项目类别:
-
资助金额:$19.45万
-
财政年份:2019
-
负责人:DANIEL W. LIN
-
依托单位:
Prostate cancer Active Surveillance Study (PASS) Cohort: Infrastructure Support for Cancer Research
-
批准号:9816560
-
项目类别:
-
资助金额:$153.45万
-
财政年份:2019
-
负责人:DANIEL W. LIN
-
依托单位:
Prostate cancer Active Surveillance Study (PASS) Cohort: Infrastructure Support for Cancer Research
-
批准号:10601448
-
项目类别:
-
资助金额:$68.39万
-
财政年份:2019
-
负责人:DANIEL W. LIN
-
依托单位:
Prostate cancer Active Surveillance Study (PASS) Cohort: Infrastructure Support for Cancer Research
-
批准号:10021612
-
项目类别:
-
资助金额:$125.93万
-
财政年份:2019
-
负责人:DANIEL W. LIN
-
依托单位:
Evaluation of commercially available prostate cancer assays to accelerate novel applications in active surveillance
-
批准号:10602926
-
项目类别:
-
资助金额:$13.19万
-
财政年份:2019
-
负责人:DANIEL W. LIN
-
依托单位:
Precision Medicine Approach to Prostate Cancer Active Surveillance
-
批准号:8899479
-
项目类别:
-
资助金额:$69.5万
-
财政年份:2014
-
负责人:DANIEL W. LIN
-
依托单位:
Precision Medicine Approach to Prostate Cancer Active Surveillance
-
批准号:9306802
-
项目类别:
-
资助金额:$69.5万
-
财政年份:2014
-
负责人:DANIEL W. LIN
-
依托单位:
Precision Medicine Approach to Prostate Cancer Active Surveillance
-
批准号:8673962
-
项目类别:
-
资助金额:$74.72万
-
财政年份:2014
-
负责人:DANIEL W. LIN
-
依托单位:
In Vivo Molecular Effects of Prostatic COX-2 Inhibition
-
批准号:6799933
-
项目类别:
-
资助金额:$12.69万
-
财政年份:2003
-
负责人:DANIEL W. LIN
-
依托单位:
In Vivo Molecular Effects of Prostatic COX-2 Inhibition
-
批准号:7117596
-
项目类别:
-
资助金额:$12.69万
-
财政年份:2003
-
负责人:DANIEL W. LIN
-
依托单位:
In Vivo Molecular Effects of Prostatic COX-2 Inhibition
-
批准号:6677519
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2003
-
负责人:DANIEL W. LIN
-
依托单位:
In Vivo Molecular Effects of Prostatic COX-2 Inhibition
-
批准号:6946300
-
项目类别:
-
资助金额:$12.69万
-
财政年份:2003
-
负责人:DANIEL W. LIN
-
依托单位:
Developmental Research Program
-
批准号:10711595
-
项目类别:
-
资助金额:$12.24万
-
财政年份:2002
-
负责人:DANIEL W. LIN
-
依托单位:
海外基金